androstenedione has been researched along with goserelin in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (11.11) | 18.7374 |
| 1990's | 15 (83.33) | 18.2507 |
| 2000's | 1 (5.56) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coombes, RC; Dowsett, M; Stein, RC | 1 |
| Coombes, RC; Ford, HT; Gazet, JC | 1 |
| Anderson, ED; Anderson, TJ; Chetty, U; Forrest, AP; Hawkins, RA; Leonard, RC | 1 |
| De Sutter, P; Dhont, M; Vandekerckhove, D; Vanluchene, E | 1 |
| Ayub, M; Levell, MJ | 1 |
| Coombes, RC; Dowsett, M; Ford, HT; Gazet, JC; Hedley, A; Stein, RC | 1 |
| Distler, W; von Matthiessen, H | 1 |
| Eidtmann, H; Jonat, W; Kügler, G; Kunz, T; Maass, H | 1 |
| Anderson, ED; Chetty, U; Forrest, AP; Hawkins, RA; Levack, PA | 1 |
| Blamey, RW; Nicholson, RI; Read, GF; Robertson, JF; Turkes, A; Walker, KJ; Walker, RF | 1 |
| Simberg, N; Stenman, UH; Tiitinen, A; Ylikorkala, O | 1 |
| Britton, J; Buamah, PK; Carmichael, J; Dowsett, M; Harris, AL; Philip, PA; Tonkin, K | 1 |
| Coombes, RC; Corbishley, C; Ford, HT; Gazet, JC; Griffin, M; Lowndes, S; Makinde, V; Quilliam, J; Sutcliffe, R | 1 |
| Burak, F; Kafkasli, A; Ozekici, U; Taskin, O; Yalcinoglu, AI | 1 |
| Anderson, ED; Anderson, TJ; Cameron, DA; Chetty, U; Forrest, AP; Hawkins, RA; Leonard, RC; Levack, P | 1 |
| Coombes, RC; Doody, D; Dowsett, M; English, J; Howes, A; Miall, S | 1 |
| Allolio, B; Arlt, W; Callies, F; Hensen, J | 1 |
| Coombes, RC; Ford, HT; Gazet, JC; Gray, R; Lowndes, S; Makinde, V; McConkey, C; Quilliam, J; Sutcliffe, R | 1 |
2 review(s) available for androstenedione and goserelin
| Article | Year |
|---|---|
Aromatization inhibition alone or in combination with GnRH agonists for the treatment of premenopausal breast cancer patients.
Topics: Androstenedione; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Buserelin; Estrogens; Female; Goserelin; Humans; Menopause | 1992 |
New trends in the endocrine treatment of breast cancer.
Topics: Androstenedione; Breast Neoplasms; Buserelin; Female; Goserelin; Humans; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen | 1990 |
10 trial(s) available for androstenedione and goserelin
| Article | Year |
|---|---|
Randomised trial of chemotherapy versus endocrine therapy in patients presenting with locally advanced breast cancer (a pilot study).
Topics: Adult; Aged; Androstenedione; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Buserelin; Female; Goserelin; Humans; Immunohistochemistry; Middle Aged; Neoplasm Staging; Pilot Projects; Receptors, Estrogen | 1991 |
Primary systemic therapy for operable breast cancer.
Topics: Adult; Aged; Aminoglutethimide; Androstenedione; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Buserelin; Combined Modality Therapy; Female; Goserelin; Humans; Lymphatic Metastasis; Middle Aged; Ovariectomy; Tamoxifen | 1991 |
The clinical and endocrine effects of 4-hydroxyandrostenedione alone and in combination with goserelin in premenopausal women with advanced breast cancer.
Topics: Adult; Androstenedione; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Buserelin; Female; Goserelin; Humans; Menopause; Middle Aged; Ovariectomy | 1990 |
New trends in the endocrine treatment of breast cancer.
Topics: Androstenedione; Breast Neoplasms; Buserelin; Female; Goserelin; Humans; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen | 1990 |
Estrogen replacement does not potentiate gonadotropin-releasing hormone agonist-induced androgen suppression in treatment of hirsutism.
Topics: Adolescent; Adult; Androgens; Androstenedione; Drug Synergism; Estradiol; Female; Goserelin; Hirsutism; Humans; Medroxyprogesterone Acetate; Sex Hormone-Binding Globulin; Testosterone | 1994 |
Hormonal treatment of pancreatic carcinoma: a phase II study of LHRH agonist goserelin plus hydrocortisone.
Topics: Adenocarcinoma; Adult; Aged; Androgens; Androstenedione; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Estradiol; Female; Follicle Stimulating Hormone; Goserelin; Humans; Hydrocortisone; Luteinizing Hormone; Male; Middle Aged; Pancreatic Neoplasms; Testosterone | 1993 |
Comparison of the effects of ovarian cauterization and gonadotropin-releasing hormone agonist and oral contraceptive therapy combination on endocrine changes in women with polycystic ovary disease.
Topics: Adult; Androstenedione; Cautery; Contraceptives, Oral; Female; Follicle Stimulating Hormone; Goserelin; Humans; Luteinizing Hormone; Ovary; Polycystic Ovary Syndrome; Prospective Studies; Sex Hormone-Binding Globulin; Testosterone | 1996 |
Primary systemic therapy for operable breast cancer--10-year survival data after chemotherapy and hormone therapy.
Topics: Adult; Aged; Aminoglutethimide; Androstenedione; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Follow-Up Studies; Goserelin; Humans; Hydrocortisone; Lymphatic Metastasis; Middle Aged; Neoplasms, Hormone-Dependent; Ovariectomy; Prednisone; Preoperative Care; Tamoxifen; Treatment Outcome; Vincristine | 1997 |
Vorozole results in greater oestrogen suppression than formestane in postmenopausal women and when added to goserelin in premenopausal women with advanced breast cancer.
Topics: Adult; Androstenedione; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Breast Neoplasms; Estradiol; Female; Goserelin; Humans; Middle Aged; Ovary; Postmenopause; Premenopause; Triazoles | 1999 |
Estrogen-receptor-directed neoadjuvant therapy for breast cancer: results of a randomised trial using formestane and methotrexate, mitozantrone and mitomycin C (MMM) chemotherapy.
Topics: Adult; Aged; Androstenedione; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Goserelin; Humans; Methotrexate; Middle Aged; Mitomycin; Mitoxantrone; Neoadjuvant Therapy; Neoplasm Metastasis; Postmenopause; Premenopause; Prognosis; Receptors, Estrogen; Survival Analysis | 2001 |
7 other study(ies) available for androstenedione and goserelin
| Article | Year |
|---|---|
Correlations between follicular fluid steroid analysis and maturity and cytogenetic analysis of human oocytes that remained unfertilized after in vitro fertilization.
Topics: 17-alpha-Hydroxyprogesterone; 20-alpha-Dihydroprogesterone; Androstenedione; Buserelin; Chromosomes; Clomiphene; Estradiol; Female; Fertilization in Vitro; Follicular Fluid; Goserelin; Humans; Hydroxyprogesterones; Karyotyping; Male; Menotropins; Oocytes; Ploidies; Progesterone; Progestins; Steroids | 1991 |
Suppression of plasma androgens by the antiandrogen flutamide in prostatic cancer patients treated with Zoladex, a GnRH analogue.
Topics: 17-alpha-Hydroxyprogesterone; Aged; Aged, 80 and over; Androgens; Androstenedione; Anilides; Antineoplastic Agents; Buserelin; Dehydroepiandrosterone; Depression, Chemical; Flutamide; Goserelin; Humans; Hydroxyprogesterones; Male; Orchiectomy; Prostatic Neoplasms; Testosterone | 1990 |
Endocrine and clinical aspects of new compounds for treatment of hormone-related cancer in gynecology.
Topics: Aminoglutethimide; Androstenedione; Aromatase Inhibitors; Breast Neoplasms; Buserelin; Female; Goserelin; Humans; Neoplasms, Hormone-Dependent; Tamoxifen | 1990 |
Response to endocrine manipulation and oestrogen receptor concentration in large operable primary breast cancer.
Topics: Aminoglutethimide; Androstenedione; Breast Neoplasms; Buserelin; Female; Goserelin; Humans; Menopause; Receptors, Estrogen; Tamoxifen | 1989 |
Review of the endocrine actions of luteinising hormone-releasing hormone analogues in premenopausal women with breast cancer.
Topics: Adult; Androstenedione; Breast Neoplasms; Buserelin; Estrone; Female; Goserelin; Humans; Middle Aged; Testosterone | 1989 |
Assesssment of the effect of pretreatment with neoadjuvant therapy on primary breast cancer.
Topics: Adult; Aged; Androstenedione; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Female; Goserelin; Humans; Immunohistochemistry; Methotrexate; Middle Aged; Mitomycin; Mitoxantrone; Neoplasms, Hormone-Dependent; Receptors, Estrogen | 1996 |
[A hairy case].
Topics: Adrenal Hyperplasia, Congenital; Alopecia; Androstenedione; Dehydroepiandrosterone Sulfate; Dexamethasone; Diagnosis, Differential; Female; Gonadotropin-Releasing Hormone; Goserelin; Hirsutism; Humans; Hydrocortisone; Middle Aged; Polycystic Ovary Syndrome; Testosterone; Treatment Outcome | 1999 |